A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C

• Main Authors: Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L
• Format: Article
• Language: English
• Published: Dove Medical Press 2015-10-01
• Series: OncoTargets and Therapy
• Online Access: https://www.dovepress.com/a-high-ldl-c-to-hdl-c-ratio-predicts-poor-prognosis-for-initially-meta-peer-reviewed-article-OTT

Fangxin Liao,1,2,* Wenzhuo He,1,2,* Chang Jiang,1,2 Chenxi Yin,1,2 Guifang Guo,1,2 Xuxian Chen,1,2 Huijuan Qiu,1,2 Yuming Rong,1,2 Bei Zhang,1,2 Dazhi Xu,1,3 Liangping Xia1,21State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 2VIP Region, 3Gastric and Pancreatic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China*These authors contributed equally to this workAbstract: Although lipid disequilibrium has been documented for several types of cancer including colorectal cancer (CRC), it remains unknown whether lipid parameters are associated with the outcome of metastatic CRC (mCRC) patients. Here, we retrospectively examined the lipid profiles of 453 mCRC patients and investigated whether any of the lipid parameters correlated with the outcome of mCRC patients. Pretreatment serum lipids, including triglyceride, cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), were collected in 453 initially mCRC patients. The LDL-C to HDL-C ratio (LHR) was calculated and divided into the first, second, and third tertiles. Univariate and multivariate analyses were performed to evaluate the impact of lipids on overall survival (OS) and progression-free survival (PFS). Nearly two-fifths of the patients (41.3%) exhibited elevations in LDL-C while most patients (88.3%) showed normal HDL-C levels. Decreased HDL-C (P=0.542) and increased LDL-C (P=0.023) were prognostic factors for poor OS, while triglyceride (P=0.542) and cholesterol (P=0.215) were not. Multivariate analysis revealed that LDL-C (P=0.031) was an independent prognostic factor. Triglyceride, cholesterol, HDL-C, and LDL-C did not correlate with PFS. Among patients with elevations in LDL-C levels, patients in the third tertile of the LHR had a markedly shorter median OS compared to those in the first or second tertile (P=0.012). Thus, increased LDL-C level is an independent prognostic factor for poor prognosis in mCRC patients, and a high LHR predicts poor prognosis for initially mCRC patients with elevations in LDL-C.Keywords: high low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, metastatic colorectal cancer